Most Common Blood Collection Tube Brands Used by U.S. Clinics

Summary

• BD Vacutainer is generally the most recognizable and widely purchased blood collection tube brand among U.S. clinics, while Greiner Bio-One VACUETTE, Cardinal Health, Sarstedt, and other regional or private-label products are also common.
• Publicly available data do not provide a definitive national ranking of tube brands purchased by clinics. Purchasing decisions depend on laboratory contracts, analyzer compatibility, Reimbursement requirements, distributor relationships, price, and supply availability.
• Clinics should evaluate tube performance, additive accuracy, specimen stability, regulatory status, staff training, and total cost rather than choosing solely by brand recognition or unit price.

Blood collection tubes are among the most frequently purchased consumable products in outpatient clinics, physician offices, hospitals, urgent care centers, reference laboratories, and Mobile Phlebotomy services across the United States. Although a tube may appear to be a simple plastic or glass container, its color, additive, material, fill volume, closure, dimensions, and manufacturing specifications can directly affect specimen quality and laboratory results.

When U.S. clinics purchase blood collection tubes, they typically select products that fit an existing Venipuncture system, laboratory contract, analyzer platform, or group purchasing organization agreement. For that reason, the most commonly purchased brands are not necessarily selected because they are universally superior. They are frequently chosen because they are familiar to phlebotomists, validated by the receiving laboratory, available through established medical distributors, and compatible with the clinic’s current supplies.

Among the brands most commonly encountered in U.S. clinical purchasing are BD Vacutainer, Greiner Bio-One VACUETTE, Cardinal Health and its private-label products, Sarstedt S-Monovette and related systems, and products from other manufacturers such as Terumo, Improve Medical, and regional private-label suppliers. BD Vacutainer is generally the most recognizable brand in the U.S. market, but the actual purchasing mix varies considerably by organization and region.

Why a Definitive National Brand Ranking Is Difficult

There is no comprehensive public database that reports every blood collection tube purchased by every U.S. clinic. Federal agencies such as the Centers for Medicare & Medicaid Services, the Centers for Disease Control and Prevention, and the U.S. Food and Drug Administration publish important information about laboratory quality, medical devices, safety, and regulation, but they do not generally publish a national clinic-by-clinic ranking of evacuated blood collection tube brands.

Commercial market research reports may estimate manufacturer revenue, market share, or product shipments, but many of those reports are proprietary. In addition, a report covering the global blood collection market may combine hospitals, laboratories, research institutions, and clinics in multiple countries. Such information cannot automatically be interpreted as a ranking of brands purchased by U.S. outpatient clinics.

Purchasing records are also fragmented. A large health system may buy directly from a manufacturer under a multiyear contract, while a small physician practice may purchase through a national distributor. Some clinics use tubes supplied by the reference laboratory that performs their testing. Others purchase private-label tubes carrying a distributor’s name even though the product is manufactured by another company.

As a result, the most accurate conclusion is based on market presence, distributor availability, clinical familiarity, and reported use rather than on a single official statistic. Clinics should treat statements about “market-leading” or “most popular” brands carefully unless the source clearly defines its geography, customer type, product category, and reporting period.

BD Vacutainer

BD Vacutainer, manufactured by Becton, Dickinson and Company, is generally the most widely recognized blood collection tube brand in the United States. The Vacutainer name has been used for decades and is familiar to laboratory directors, nurses, medical assistants, phlebotomists, distributors, and purchasing departments.

BD offers a broad range of evacuated blood collection tubes, including serum tubes, serum separator tubes, plasma separator tubes, lithium Heparin tubes, Sodium Citrate coagulation tubes, EDTA tubes, fluoride-containing tubes, trace-element tubes, and specialized products for molecular or microbiology testing. The breadth of the portfolio is a major reason many clinics standardize on the brand.

BD tubes are commonly purchased in conjunction with other products in the same ecosystem, such as needles, holders, butterfly sets, transfer devices, urine collection products, and safety-engineered blood collection equipment. A health system may prefer one vendor because standardized ordering can simplify inventory management, staff training, product evaluation, and contract administration.

Another factor is laboratory familiarity. Many reference laboratories and hospital laboratories have established specimen acceptance criteria for BD tubes. If a clinic changes brands, the receiving laboratory may require verification or written approval, particularly for coagulation, special chemistry, molecular, Therapeutic Drug Monitoring, or trace-element testing.

BD Vacutainer products are often selected by large hospitals and multisite health systems, but they are also widely available to independent clinics. The brand’s strong distribution network makes it relatively easy to source through national medical suppliers, regional distributors, and health system purchasing contracts.

Common BD Vacutainer Tube Categories

1. Gold or tiger-top serum separator tubes for many routine chemistry and immunology tests.
2. Red-top tubes for serum collection when a gel separator is not required.
3. Lavender-top EDTA tubes for hematology testing, including complete blood counts.
4. Light-blue Sodium Citrate tubes for coagulation studies.
5. Green-top Heparin tubes for plasma chemistry and selected special testing.
6. Gray-top tubes containing glycolysis inhibitors for selected glucose or lactate applications.
7. Royal-blue or specialized trace-element tubes for testing in which contamination control is important.

Clinics should not assume that every tube with the same color is interchangeable. Additive concentration, gel formulation, tube size, draw volume, separator characteristics, and testing requirements can differ between products. The laboratory performing the test should determine which BD product is acceptable for each order.

Greiner Bio-One VACUETTE

Greiner Bio-One’s VACUETTE brand is another major name in blood collection tubes used by U.S. healthcare organizations. Greiner Bio-One is headquartered in Austria and has a substantial international presence, including distribution and commercial activity in the United States.

VACUETTE products are used in hospitals, physician offices, reference laboratories, diagnostic centers, and other healthcare settings. The portfolio includes evacuated blood collection tubes for serum, plasma, hematology, coagulation, glucose, trace-element, and specialized applications. Greiner also supplies compatible blood collection needles, holders, safety devices, and related laboratory consumables.

Many laboratories consider VACUETTE when seeking a second source, negotiating supply contracts, or evaluating alternatives during shortages. The brand can also be attractive to organizations that already use other Greiner laboratory products or that want to consolidate orders with one supplier.

VACUETTE tubes are frequently discussed in the context of standardization and specimen quality. Features such as tube vacuum, closure design, additive distribution, gel performance, labeling, and tube geometry can influence the ease of collection and processing. However, the suitability of a particular VACUETTE tube depends on the testing laboratory’s validation and the instructions for use.

During periods of medical supply disruption, clinics may encounter both BD and Greiner products as approved alternatives. A substitution should never be made solely because the replacement tube has the same cap color. The clinic should confirm that the alternative has the same additive, intended specimen type, minimum and maximum fill requirements, processing instructions, and laboratory acceptance status.

Cardinal Health and Private-Label Products

Cardinal Health is one of the largest healthcare services and medical product companies operating in the United States. Its distribution network supplies hospitals, physician practices, ambulatory surgery centers, laboratories, and other Healthcare Providers. Depending on the product category and purchasing agreement, clinics may purchase blood collection tubes under a Cardinal Health label or obtain major manufacturer products through Cardinal Health distribution.

Private-label purchasing can make brand comparisons more complicated. A clinic may see the distributor’s name on an invoice while the physical packaging identifies a different manufacturer. In other cases, the product is marketed under a private label with limited brand recognition outside the distributor’s customer base.

Private-label tubes are often considered when a clinic wants lower unit costs, simplified procurement, or an alternative during shortages. They may be perfectly suitable when they meet applicable regulatory requirements and have been accepted by the testing laboratory. However, purchasers should document the actual manufacturer, catalog number, lot number, additive, expiration date, and product specifications.

The lowest quoted price is not necessarily the lowest total cost. A less expensive tube can create additional expenses if it causes redraws, Specimen Rejection, delayed results, staff confusion, or incompatibility with automated processing equipment. Clinics should compare total cost per acceptable reportable specimen rather than only cost per tube.

Sarstedt

Sarstedt is a well-established laboratory and medical products manufacturer whose blood collection systems are used internationally and in the United States. The company is particularly known for the S-Monovette system, which can support blood collection using aspiration or a vacuum-based method, depending on the configuration.

Sarstedt products are used by hospitals, laboratories, specialty clinics, research organizations, and healthcare systems that have adopted the company’s collection platform. Its tubes and collection devices may be especially visible in organizations that value a coordinated system involving tubes, needles, holders, transport products, and specimen processing supplies.

The S-Monovette design differs from the traditional evacuated tube approach used by many other systems. In some settings, the ability to collect by aspiration can be useful for difficult draws, pediatric patients, fragile veins, or situations in which controlling collection pressure is important. Whether a clinic benefits from that design depends on staff training, laboratory Workflow, and the equipment already in use.

Sarstedt tubes may not be the first brand named by a small primary care office, but they are a significant option in the U.S. clinical market. Purchasing departments should evaluate the complete collection system rather than comparing a Sarstedt tube with a conventional evacuated tube based only on cap color or package quantity.

Other Brands and Regional Suppliers

Several other manufacturers supply blood collection tubes to U.S. clinics. Terumo offers blood collection and safety products in various markets, while Improve Medical manufactures and distributes medical consumables that may include blood collection tubes and related devices. Additional suppliers serve specific regions, laboratory networks, specialty testing segments, or government and institutional contracts.

Some clinics also purchase tubes through laboratory companies or specialized distributors. In these cases, the package may carry a laboratory-specific label, a distributor brand, or a manufacturer name that is less familiar to front-line staff. The product may still be appropriate, but the clinic should maintain clear documentation about its source and specifications.

Regional availability can have a major effect on purchasing frequency. A brand that is common in one state or hospital network may be rarely seen in another. Group purchasing organization agreements may also produce different outcomes. A clinic affiliated with a large health system may be required to use the contracted brand, while an independent practice may have greater flexibility to compare several suppliers.

How Clinics Decide Which Tube Brand to Buy

Compatibility With Laboratory Testing

The most important purchasing consideration is whether the tube is approved for the tests the clinic orders. A laboratory may specify serum, plasma, whole blood, or a particular anticoagulant. It may also identify acceptable tube types by manufacturer and catalog number.

For example, an EDTA tube commonly used for a complete blood count is not automatically suitable for chemistry testing. A Sodium Citrate tube for coagulation testing requires an accurate blood-to-Anticoagulant ratio. A serum separator tube may be appropriate for many chemistry assays but unsuitable for certain specialized tests. Tube selection must therefore be based on the laboratory’s test directory and specimen requirements.

Regulatory and Quality Requirements

Blood collection tubes are medical devices and are subject to U.S. regulatory requirements. Depending on the product and intended use, manufacturers may need to comply with applicable Food and Drug Administration requirements, quality-system Regulations, labeling rules, and post-market obligations.

Clinics should purchase from reputable, authorized sources and retain documentation such as product descriptions, lot numbers, expiration dates, certificates, and manufacturer instructions. The purchase file should identify the intended use and any laboratory approval associated with the product.

Clinical laboratories operating under the Clinical Laboratory Improvement Amendments must ensure that specimen collection and handling procedures support accurate testing. The Centers for Medicare & Medicaid Services oversees CLIA, while accreditation organizations may impose additional requirements. Although CLIA does not prescribe one universal tube brand, it requires laboratories to maintain processes that support reliable results.

Specimen Rejection and Redraw Rates

Specimen Rejection is a meaningful operational and financial issue. Common causes include hemolysis, clotting, insufficient quantity, incorrect tube type, underfilling, contamination, labeling errors, and delays in transport or processing.

Published studies and laboratory quality programs frequently report Specimen Rejection rates below 2% for many routine settings, although rates vary substantially by facility, test type, patient population, and measurement method. Hemolysis is often one of the leading causes of rejection in emergency and outpatient environments. A tube brand cannot eliminate all preanalytical errors, but tube quality, draw consistency, stopper design, additive performance, and staff technique may affect outcomes.

Before changing brands, clinics should establish baseline data. Useful measures include rejected specimens per 1,000 collections, redraws per 1,000 collections, hemolysis rates, underfilled citrate tubes, clotted EDTA tubes, and delayed-result incidents. A purchasing decision based on local performance data is more reliable than a decision based only on catalog price.

Supply Continuity

Blood collection tubes are essential consumables, so an interruption can quickly affect patient care. The Covid-19 pandemic demonstrated how disruptions in manufacturing, transportation, raw materials, and healthcare demand can influence the availability of tubes and related products.

Clinics should assess lead times, minimum order quantities, allocation policies, back-order history, distributor inventory, and the availability of approved substitutes. Maintaining a documented secondary source can reduce risk, but the alternative product should be evaluated before an emergency occurs.

For critical tube types, many organizations maintain safety stock based on historical usage and supplier lead time. A clinic may calculate average weekly consumption, add expected growth, and establish a reorder point that accounts for delivery variability. Excessive inventory can create expiration and storage problems, while inadequate inventory can force unvalidated substitutions.

Cost and Contract Terms

Tube prices vary according to size, additive, packaging, special coating, regulatory requirements, order volume, and contract terms. Routine serum or EDTA tubes generally cost less than specialized trace-element, molecular, pediatric, or low-volume tubes.

Purchasers should compare the delivered cost, including freight, handling, distributor fees, minimum-order requirements, and storage expenses. Contract pricing may also depend on bundled purchases of needles, holders, safety devices, and other laboratory products.

Cost-per-test analysis is more useful than cost-per-box analysis. For instance, a tube that costs slightly more but reduces redraws and Specimen Rejection may lower overall operating costs. Clinics should also consider staff time, patient inconvenience, delayed treatment, recollection supplies, and potential Reimbursement consequences.

Understanding Tube Colors and Additives

Tube colors provide a useful visual shorthand, but they are not a universal substitute for reading the label. Color conventions can vary by manufacturer, product family, country, and specialized testing application. The additive and intended use are more important than the color alone.

1. Light-blue tubes generally contain buffered Sodium Citrate and are used for many coagulation studies. The tube must usually be filled to the required level to preserve the correct blood-to-Anticoagulant ratio.
2. Red tubes generally contain no anticoagulant, although some products may include Clot Activator. They are used for serum collection in accordance with laboratory instructions.
3. Gold or tiger-top tubes commonly contain Clot Activator and gel separator for serum testing. The tube must clot and be centrifuged according to the laboratory’s procedure.
4. Green tubes generally contain Heparin, often lithium Heparin, for plasma chemistry or selected specialized tests.
5. Lavender or purple tubes generally contain EDTA and are widely used for hematology testing.
6. Gray tubes commonly contain additives such as Sodium Fluoride and an Anticoagulant for selected glucose, lactate, or related applications.
7. Royal-blue or tan tubes may be used for trace-element, Toxicology, or specialized testing, with the correct additive and contamination-control specifications determined by the laboratory.

The order of draw is another important consideration. The commonly taught sequence helps reduce additive carryover between tubes. The exact procedure should follow current laboratory policy and the instructions for the collection system in use.

What Data Should a Clinic Review Before Purchasing?

A responsible purchasing review should combine clinical, operational, financial, and regulatory information. Clinics should examine at least the following data:

1. Monthly and annual usage by tube type, size, additive, and department.
2. Number of rejected specimens and redraws associated with each tube category.
3. Hemolysis, clotting, underfill, leakage, and labeling-error rates.
4. Average supplier lead time and the frequency of back orders.
5. Expiration-related waste and damaged inventory.
6. Unit price, freight, contract discounts, and minimum-order requirements.
7. Compatibility with analyzers, Pneumatic Tube Systems, centrifuges, aliquoting equipment, and laboratory information systems.
8. Training time required for phlebotomists, nurses, medical assistants, and specimen-processing staff.
9. Laboratory approval and any validation or verification required before implementation.
10. Manufacturer complaint history, recall notices, and distributor responsiveness.

Because the U.S. Bureau of Labor Statistics projects continued demand for phlebotomists and other healthcare workers, ease of use and training efficiency are also important. A product that requires complicated handling or creates uncertainty among inexperienced staff may increase preanalytical errors, especially in high-volume clinics.

Best Practices for Buying Blood Collection Tubes

Confirm the Exact Product

Every purchase order should identify the manufacturer, product name, catalog number, tube material, size, additive, closure color, draw volume, packaging configuration, and expiration requirements. “Lavender tube” or “gold tube” is not sufficiently specific for a large or complex purchasing program.

Involve the Testing Laboratory

The laboratory that performs the testing should participate in product selection. It can confirm whether a tube is validated for the intended assays and whether a change could affect specimen stability, centrifugation, analyzer operation, or result interpretation.

Conduct a Controlled Evaluation

When moving to a new brand, clinics should conduct a limited evaluation before full conversion. The evaluation can compare collection success, fill accuracy, clot formation, hemolysis, leakage, labeling, centrifugation performance, and laboratory rejection rates.

Train Staff Before the Change

Training should cover tube identification, order of draw, inversion requirements, minimum fill lines, Clotting Time, handling, transport, and storage. Staff should understand that the new product may look similar to the previous tube while having different instructions.

Maintain Approved Alternatives

Supply resilience is strongest when the clinic has an approved primary product and at least one evaluated alternative. The laboratory should document which substitutions are allowed and under what circumstances. An emergency substitution should not be improvised at the collection chair.

Are More Expensive Tubes Better?

Price alone does not establish quality. A premium brand may offer strong distribution, extensive product documentation, consistent lot performance, and broad laboratory acceptance. A lower-priced private-label tube may also perform well when it is manufactured under appropriate controls and validated for the clinic’s intended use.

The correct question is whether the product consistently produces an acceptable specimen at a reasonable total cost. A high-quality purchasing assessment considers safety, reliability, compatibility, availability, and clinical consequences. Clinics should avoid assuming that a familiar brand is automatically appropriate for every test or that a less familiar brand is automatically inferior.

Conclusion

BD Vacutainer is generally the blood collection tube brand most commonly recognized and purchased by clinics in the United States. Greiner Bio-One VACUETTE is also a major and widely used option, while Cardinal Health distribution and private-label products, Sarstedt systems, Terumo products, Improve Medical products, and regional suppliers contribute to a diverse market.

However, there is no publicly available, definitive national ranking that captures every U.S. clinic purchase. Brand prevalence depends on health-system contracts, distributor relationships, laboratory requirements, geography, supply conditions, and the type of testing performed. The same clinic may use several brands for different departments or specialized assays.

For purchasing teams, the best choice is the product that satisfies the receiving laboratory’s requirements, supports reliable specimen collection, remains available through dependable channels, and provides a favorable total cost of ownership. Before changing brands, clinics should compare additive specifications, regulatory documentation, specimen performance, staff training needs, supply continuity, and local rejection data. In blood collection, consistency and validated compatibility are usually more important than brand popularity alone.

Disclaimer: The content provided on this blog is for informational purposes only, reflecting the personal opinions and insights of the author(s) on the topics. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. No contributors to this web site make any representations, express or implied, with respect to the information provided herein or to its use. While we strive to share accurate and up-to-date information, we cannot guarantee the completeness, reliability, or accuracy of the content. The blog may also include links to external websites and resources for the convenience of our readers. Please note that linking to other sites does not imply endorsement of their content, practices, or services by us. Readers should use their discretion and judgment while exploring any external links and resources mentioned on this blog.

Related Videos